Lymphoid leukosis is a tumor-forming disease of chickens caused by avian leukosis virus (ALV), a retrovirus that inserts its genetic material into a bird’s DNA and, in some cases, switches on a cancer-promoting gene. The disease typically appears in birds older than 14 weeks and produces tumors of B lymphocytes, a type of white blood cell, in organs throughout the body. While mortality from the tumors themselves can be modest in a flock, the broader economic damage from reduced egg production, poor hatchability, and subclinical infection makes lymphoid leukosis one of the more costly viral diseases in commercial poultry.
How the Virus Triggers Tumors
ALV does not carry its own cancer gene. Instead, it causes tumors through a process called insertional mutagenesis. When the virus integrates its DNA into the chicken’s genome, it occasionally lands next to a normal cellular gene called c-myc, which regulates cell growth. The viral DNA contains a powerful genetic switch known as a long terminal repeat (LTR), and when that switch ends up near c-myc, it can force the gene to stay active far beyond normal levels, pushing the cell toward uncontrolled division.
Researchers examining dozens of ALV-induced lymphomas found that the vast majority contained a proviral insertion in or near c-myc, with most of those insertions sitting upstream of the gene’s protein-coding region and oriented in the same direction as c-myc itself.1PubMed Central. Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas In every case, the integrated provirus had deletions removing some of its own genes, leaving behind a stripped-down piece of viral DNA that functions mainly as a promoter for c-myc. In some tumors, the entire provirus has been reduced by recombination to a single LTR sitting in just the right spot to drive the oncogene.2PubMed Central. Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors Additional point mutations in the c-myc coding sequence, including changes that alter the resulting protein, have been documented in some tumors, suggesting that tumor progression involves more than just switching c-myc on.
This mechanism is slow and probabilistic. The virus integrates randomly, and landing near c-myc in a B lymphocyte that then expands into a tumor is a relatively rare event. That is why lymphoid leukosis typically shows up only after months of infection and why only a fraction of infected birds ever develop visible tumors.
How ALV Spreads Through a Flock
ALV travels two main routes: from hen to offspring through the egg (vertical transmission) and from bird to bird in the environment (horizontal transmission). Vertical transmission is the more consequential path because chicks that hatch already infected are exposed to the virus before their immune system matures. These congenitally infected birds tend to produce high concentrations of virus throughout their lives without ever mounting an antibody response, a state described as immunological tolerance.3Virology. Tolerance and immunity in chickens after congenital and contact infection with an avian leukosis virus A tolerant bird becomes a persistent shedder, silently seeding virus into the flock.
Horizontal spread occurs through feces, saliva, and shed skin cells, but it moves slowly compared to many other poultry viruses.4PubMed. Progress towards eradication of lymphoid leukosis viruses–a review Birds infected horizontally after hatching usually develop an immune response and clear the virus or at least limit it. The trouble is that horizontal infection often produces persistent, low-level infections that are hard to detect with routine screening. These quietly infected hens may not show obvious signs yet still shed virus into their eggs, perpetuating the cycle.
Artificial insemination, widely used in commercial breeding, adds another wrinkle. When hens were inseminated with semen from ALV-J-positive roosters, roughly one in nine of the resulting eggs tested positive for viral antigen in the albumen, confirming that the virus had reached the reproductive tract and entered the egg.5PubMed Central. Vertical transmission of avian leukosis virus subgroup J (ALV-J) from hens infected through artificial insemination with ALV-J infected semen This route means even biosecure breeding programs that prevent direct bird-to-bird contact can inadvertently spread ALV if semen donors are not screened.
What Lymphoid Leukosis Looks Like in Affected Birds
Lymphoid leukosis tumors are masses of transformed B lymphocytes. They grow in multiple organs, most commonly the liver, spleen, kidneys, bursa of Fabricius, bone marrow, and gonads.6Journal of Veterinary Medical Science. Rapid Induction of Lymphoid Leukosis and Ascites by Avian Leukosis Virus from a Lymphoid Leukosis Cell Line The liver is often massively enlarged and studded with pale nodules, giving it a mottled appearance. The bursa of Fabricius, an organ unique to birds that serves as the birthplace of B cells, is a primary site of tumor initiation.
Birds with advanced disease lose weight, appear pale due to internal bleeding or anemia, and may develop a swollen abdomen from liver enlargement or fluid accumulation. But many infected birds never reach this point. They live and produce, albeit at a reduced level, without showing tumors at all. The subclinical effects are where most of the economic damage accumulates.
The Production Losses You Do Not See
Flock managers sometimes underestimate lymphoid leukosis because mortality from actual tumors tends to stay low. The real cost is in productivity. In a detailed study comparing virus-shedding hens to non-shedders in the same flock, the shedders produced 25 to 30 fewer eggs per hen over a laying cycle that ran to about 500 days of age. Those birds also matured later, laid smaller eggs, and produced eggs with thinner shells.7PubMed. Lymphoid leukosis virus infection: effects on production and mortality and consequences in selection for high egg production Mortality from all causes was also higher in the shedding group, with an increase of nearly 15 percentage points in one year of the study, though the increase was smaller and not statistically significant the following year. Mortality from leukosis tumors specifically stayed very low in both years.
This pattern makes ALV infection a hidden drag on genetic improvement as well. Breeding programs that select hens on egg production may inadvertently favor birds that happen to be uninfected rather than birds with genuinely superior genetics. If the virus circulates in the breeding population, it confounds the selection signal, slowing genetic gains for traits like egg number and shell quality.
Telling It Apart from Marek’s Disease
Marek’s disease is the other major tumor-causing disease of chickens, and the two can look remarkably similar at necropsy. Both produce enlarged organs with pale tumorous masses, and in a mixed-age flock both can appear in young adults. Gross examination alone often cannot tell them apart.8PubMed Central. Cytological and immunocytological detection and differentiation of Marek’s disease and lymphoid leucosis in poultry The differences matter for management decisions: Marek’s disease has a widely used vaccine; lymphoid leukosis does not.
There are a few distinguishing features. Lymphoid leukosis involves B lymphocytes and originates in the bursa of Fabricius, while Marek’s disease involves T lymphocytes and often affects peripheral nerves, causing leg paralysis. Lymphoid leukosis rarely appears before 14 weeks of age, whereas Marek’s disease can strike younger birds. But overlap in organ involvement and bird age is common enough that laboratory confirmation is often needed. Immunocytology using antibodies specific to Marek’s oncoprotein (Meq) or to IgM on transformed B cells can definitively distinguish the two. In one large diagnostic effort, this approach identified over 500 cases as Marek’s disease and 77 as lymphoid leukosis from a pool that could not be differentiated by gross pathology alone.
Testing and Screening for ALV
Detecting ALV in a flock relies on finding either viral protein or viral genetic material. The most widely used screening tool is an ELISA test for p27, a group-specific antigen shared by all ALV subgroups. This test can be run on blood, egg albumen, cloacal swabs, or meconium from newly hatched chicks. It is relatively cheap and scalable, which matters when you need to screen thousands of birds in a breeding program.
However, p27 ELISA has sensitivity limits. A more targeted sandwich ELISA applied to chick meconium samples detected twice as many positive birds as a standard commercial kit in one comparison of over 1,800 samples.9PubMed Central. Detection of ALV p27 in cloacal swabs and virus isolation medium by sELISA PCR-based methods offer higher sensitivity still. A real-time PCR assay developed specifically for the recently identified subgroup K was 100 times more sensitive than conventional PCR and 10 times more sensitive than p27 ELISA, detecting as little as a single infectious unit of virus in cultured cells.10PubMed Central. Development and application of a SYBR green real-time PCR for detection of the emerging avian leukosis virus subgroup K
Subgroup-specific detection matters because different ALV subgroups use different cell-surface receptors and can have different clinical profiles. A test that identifies only one subgroup could miss a co-infection with another. Cross-priming amplification, a rapid isothermal method that does not require a thermal cycler, has also been adapted for ALV-J detection, offering a faster turnaround option for field settings.11Scientific Reports. Rapid detection of avian leukosis virus subgroup J by cross-priming amplification
Why ALV Subgroups Matter
ALV is classified into subgroups based on its envelope (env) gene, which determines which receptor the virus uses to enter cells. The classical subgroups A through E have been known for decades, but the landscape shifted with the emergence of subgroup J in the late 1980s. ALV-J uses a completely different receptor from the older subgroups, giving it broader cell tropism and making it more transmissible.12PubMed. Role of env gene and LTR sequence in the pathogenesis of subgroup K avian leukosis virus It is now considered the most pathogenic and prevalent ALV subgroup worldwide. ALV-J tends to cause myeloid tumors (myelocytomatosis) in addition to lymphoid leukosis, broadening the spectrum of disease it produces.
In local chicken populations in China, screening of dozens of field isolates found that all belonged to subgroup J, with no subgroups A through E or K detected, reflecting J’s dominance in the field.13Scientific Reports. Diversity of Avian leukosis virus subgroup J in local chickens, Jiangxi, China ALV-J’s ability to recombine with endogenous retroviral sequences in the chicken genome adds to its adaptability and complicates eradication. A newer subgroup, ALV-K, was identified more recently and causes milder symptoms, but its discovery underscores that the virus continues to evolve and that surveillance cannot afford to target only known variants.
Endogenous Virus and the Chicken Genome
One of the complicating factors in leukosis biology is that chickens carry fragments of ALV-related sequences already embedded in their own genome, inherited like any other gene. These endogenous viral loci, called ev loci, arose from ancient infections where the virus integrated into germ-line cells and became part of the heritable genome. Some ev loci are essentially silent, while others express viral proteins or even produce virus-like particles.14PubMed. Exogenous and endogenous leukosis virus genes–a review
Endogenous viral expression creates problems for both diagnosis and disease control. Chickens expressing endogenous virus can test positive on p27 ELISA even when they are not infected with exogenous (disease-causing) ALV, producing false positives. On the flip side, endogenous viral proteins can interfere with the immune response to exogenous virus. Breeding lines with fewer active ev loci tend to have better resistance to exogenous ALV, and over time, natural selection appears to disfavor the ev loci that express high levels of virus. Still, fully eliminating endogenous viral expression through conventional breeding is extremely difficult because the loci are scattered across the genome.
Natural Genetic Resistance
Some chickens are naturally resistant to certain ALV subgroups because of mutations in the receptor genes the virus needs to enter cells. The best-characterized example involves the tvb receptor, which normally serves as the entry point for ALV subgroups B, D, and E. A resistance allele called tvb(r) carries a single-base mutation that creates a premature stop in the gene, producing a severely shortened protein that the virus cannot use.15PubMed Central. Resistance to infection by subgroups B, D, and E avian sarcoma and leukosis viruses is explained by a premature stop codon within a resistance allele of the tvb receptor gene Birds homozygous for this allele are fully resistant to infection by those three subgroups.
Similar receptor-based resistance exists for other subgroups. However, ALV-J side-stepped the old receptor landscape entirely by evolving to use a different protein, chNHE1, as its receptor. This meant that chicken lines bred for resistance to subgroups A through E had no built-in protection against J when it emerged. The discovery of each subgroup’s receptor has opened the door to more targeted approaches, including gene editing, but it also illustrates a recurring challenge: the virus can jump to a new receptor and render existing resistance irrelevant.
Eradication Through Test-and-Remove Programs
Because no effective vaccine exists for lymphoid leukosis, the primary control strategy has been to eliminate the virus from breeding flocks through systematic testing and removal of infected birds. The logic is straightforward: if you can identify and cull every shedding bird before it passes the virus to the next generation, you can break the transmission cycle. In practice, this requires frequent, sensitive testing and rigid biosecurity.
A well-documented eradication program in a Russian broiler cross illustrates both the feasibility and the difficulty. The program began with a subgroup J positive rate of about 52% and used a multilocus PCR system to identify infected birds. Subgroup K viruses disappeared by the fourth testing cycle, suggesting they were easier to clear. Subgroup J took eight cycles of selection before it was no longer detected in two of the four breeding lines.16PubMed Central. Eradication of avian leukosis virus subgroups J and K in broiler cross chickens by selection against infected birds using multilocus PCR A critical lesson from that program was the importance of testing frequency: when the interval between tests was stretched to about two months, infection rates doubled, likely because infected birds had time to spread virus before being removed. Testing every two weeks proved necessary to maintain progress.
The sensitivity of the detection method also matters. Standard ELISA can miss low-level infections, and the high variability of ALV-J genomes means a PCR assay targeting a single genomic region can miss divergent strains. The successful program addressed this by adding multiple PCR targets, including one for a J-specific LTR fragment, which caught variants that single-target assays missed. These details make eradication programs expensive and labor-intensive, which is why they are concentrated in elite breeding stock rather than applied at the commercial production level.
Gene Editing as a Future Defense
The identification of chNHE1 as the receptor for ALV-J opened a precise genetic target. Researchers used CRISPR/Cas9 to delete a single amino acid (tryptophan at position 38, abbreviated W38) from the chNHE1 protein in chicken primordial germ cells, then bred those cells into live birds. Chickens homozygous for the W38 deletion were completely resistant to ALV-J infection in both cell culture and live challenge experiments, while heterozygous birds and wild-type birds remained susceptible.17PubMed Central. Precise CRISPR/Cas9 editing of the NHE1 gene renders chickens resistant to the J subgroup of avian leukosis virus The deletion produced no visible side effects in the edited birds, which is a meaningful result because chNHE1 has essential cellular functions beyond serving as a viral receptor.
A separate group achieved the same W38 deletion in a commercial chicken line and confirmed that the modification completely protected cells from ALV-J infection.18Frontiers in Genome Editing. Acquiring Resistance Against a Retroviral Infection via CRISPR/Cas9 Targeted Genome Editing in a Commercial Chicken Line The fact that two independent groups reached the same result with the same edit strengthens confidence that the approach is reliable. Whether gene-edited chickens will reach commercial flocks depends less on the biology than on regulatory frameworks: most countries have not yet established clear pathways for approving gene-edited livestock for food production.
Even if regulatory approval comes, gene editing solves only part of the problem. The W38 deletion blocks ALV-J specifically, but it does nothing against subgroups A through E, which use entirely different receptors. A comprehensive genetic defense would require stacking edits against multiple receptors, and the emergence of new subgroups could outpace the editing pipeline. Still, for the single most economically damaging subgroup circulating today, the proof of concept is solid and the approach is far more targeted than culling entire breeding lines.
Why There Is No Vaccine
The absence of a lymphoid leukosis vaccine stands out given that Marek’s disease, the other major tumor virus of chickens, has been controlled by vaccination since the 1970s. The fundamental obstacle is immunological tolerance. Because ALV transmits vertically through the egg, many chicks hatch already carrying the virus. Their immune system treats it as “self” and never mounts a response. A vaccine given to a congenitally infected chick would have nothing to work with, since the bird’s immune system has already decided the virus belongs there.
ALV’s retroviral biology adds another layer of difficulty. The virus integrates into host DNA, meaning that even a robust immune response in a horizontally infected bird cannot clear proviral copies already embedded in the genome. Retroviruses are also notoriously variable, and ALV-J in particular is a multi-recombinant that has incorporated sequences from endogenous retroviruses, giving it a moving target of surface proteins. The combination of tolerance in congenitally infected birds, proviral persistence in all infected birds, and antigenic variability makes vaccine development a fundamentally different challenge than it was for Marek’s disease, which is caused by a herpesvirus with different biology at every level.